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Background: The Belgian care trajectory (CT) for diabetes mellitus type 2 (T2DM), implemented in September 2009,
aims at providing integrated, evidence-based, multidisciplinary patient- centred care, based on the chronic care model.
The research project ACHIL (Ambulatory Care Health Information Laboratory) studied the adherence of CT
patients, in the early phases of CT programme implementation, with CT obligations, their uptake of incentives for
self-management, whether the CT programme was targeting the appropriate group of patients, how care processes for
these patients evolved over time and whether CT start led to better quality in the processes and outcomes of care.
Methods: This observational study took place in the period 2006–2011 and covered T2DM patients who started a CT
between 01/09/2009 and 31/12/2011.
Four data sources were used: outcome data, from electronic patient records (EPRs) on all CT patients, provided by
general practitioners (GPs); reimbursement process data on all CT patients and clinically comparable patients; and
data from a sample of CT patients and clinically comparable patients from an EPR-based regional GP network and
a paper-based national GP network, respectively.
Through multilevel analysis of cross-sectional and longitudinal data, the effect of CT inclusion on processes and
outcome was estimated, controlling for potential confounders.
Results: By the end of 2011, data on 18,250 CT patients had been collected. Approximately 50 % of these CT
patients had received reimbursement for a glucometer and nearly 60 % had had at least one encounter with a
diabetes educator. The CT programme recruited T2DM patients who had been difficult to control in the past. In
the years prior to CT start, there had been a gradual improvement in the follow up of these patients. Moreover,
compared to non-CT patients, the proportion of CT patients adhering to the recommended frequency for monitoring
of parameters, such as HbA1c, increased significantly around CT start. Some data sources, albeit not all, suggested there
had been an improvement in certain outcomes, such as HbA1c, after CT inclusion.
Conclusions: According to this study, CT enrolment is associated with better quality of care processes compared to
non-CT patients. This improvement was found in several of the data sources used in this study. However, results on
outcome parameters remain inconclusive.
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The Belgian health care system is based on a compulsory
insurance system, which covers 99 % of the population
for a wide range of health conditions. The health system
focuses mainly on acute diseases and hospital care. Fee-
for-service payments apply to most ambulatory and medical
services, delivered by self-employed health professionals.
Patients are free to choose their health care professional.
General practitioners (GPs) have no formal gate-keeping
function and patients have direct access to specialists
and emergency services. Nevertheless, the national Health
Interview Survey (HIS) of 2013 showed that a large major-
ity of the population (94 %) has a regular GP, and that the
mean number of contacts per year is 3.9 (self-reported by
the patient) [1]. Moreover, a number of decisions were
taken in past years to reassess and strengthen primary
care. Among these, the Global Medical File (GMF) was
established in 1999 to increase the availability of medical,
social and administrative patient information and access
to such information. The GP holds the GMF with the
patient’s consent and shares relevant information with
other providers responsible for the patient. Only one GP
can hold the patient’s file.
Primary care is dominated by single-handed, self-
employed practices for general practice, physiotherapy,
speech therapy and so on, with only a limited number
of integrated primary care centres. The number of such
practices is growing, although there is still only a small
minority of people affiliated to them.
As in most other European countries, the Belgian
health care system is struggling with changing health
care needs. Higher life expectancy is associated with an
increasing prevalence of chronic diseases such as diabetes
mellitus type 2 (T2DM), which has a growing impact on
healthcare delivery and costs.
Up to 2009, the main government regulation in dia-
betes care was the so-called diabetes convention “786”.
Since 1988, Belgian multidisciplinary hospital-based dia-
betic centres (over 100) can conclude a diabetes conven-
tion with the National Institute for Health and Disability
Insurance (NIHDI). This convention aims at providing a
self-regulation programme for people with diabetes. Ini-
tially, this convention targeted only type 1 diabetes mellitus
(T1DM) and later on, the target public also included the
growing number of patients with T2DM with at least 2
insulin injections a day. When the latter adhere to such
a diabetic centre, they are followed up by a multidiscip-
linary diabetes team led by an endocrinologist. They receive
reimbursement of diabetes education and self-monitoring
materials and get access to specialised advice, e.g. podiatry
and cardiology. According to the number of insulin in-
jections a day and glycaemic self-control measurements,
various subcategories of the diabetes convention exist, e.g.
convention 3A concerns patients with two or more insulininjections a day and more than 30 glycaemic measure-
ments a month. In 2001 a quality improvement initiative,
called IQED and run by the Scientific Institute of Public
Health, was installed [2, 3]. Since 2005 a diabetic foot con-
vention exists between the NIHDI and over 30 diabetic
multidisciplinary foot clinics, organised in larger hospitals,
focusing on prevention and treatment of complex dia-
betic foot problems. A quality improvement initiative,
the so called IQED Foot project is linked to this con-
vention [4].
With the growing number of patients with T2DM, in-
cluding those on insulin therapy, the diabetes convention
more and more suffered from its historical weaknesses.
First, the programme only targets diabetes patients with
insulin therapy. All other diabetics, according to the HIS
2013 approximately 72 % of the diabetic population [5],
were excluded from this care programme and had to make
considerable contributions for dietetic and podiatric ser-
vices and self-monitoring materials. Even a subpopulation
of insulin-treated diabetes patients, those on one daily in-
jection were excluded from this care programme as well
as from the reimbursement of the necessary blood glucose
monitoring material.
Further on, the diabetes convention also resulted in most
diabetes patients on insulin being treated in secondary
care, while many of those patients (especially those who
need 2 doses of insulin a day) could be cared in primary
care with the pivotal role of the GP. Moreover, insulin ther-
apy being monopolized in diabetes centres, GPs risked to
lose the necessary competences to initiate and follow-up
insulin therapy. On the other hand, with the growing
number of diabetes patients, the convention centres risked
to be overwhelmed.
For all these reasons, there was an urgent need to re-
organise the managed care for people with diabetes. Within
this new system the diabetes convention could focus
on diabetics with complex insulin schemes or severe
complications.
However, Goderis et al. found in 2006 a better overall
metabolic control in T2DM patients followed up in dia-
betic convention centres (with more structured care com-
pared to primary care), compared to diabetics followed up
in primary care [6].
On the other hand, Goderis et al. illustrated that a
multifaceted diabetes programme in general practice with
various interventions, such as a clear treatment protocol,
postgraduate education of GPs, case-coaching by an endo-
crinologist, benchmarking feedback and possibility of
patient’s referral for diabetes education free of charge,
substantially improved quality of care and major diabetes-
related patient outcomes [7].
In 2006, the Belgian Health Care Knowledge Centre
(KCE) recommended a new organisation of the care for
the rapidly increasing T2DM patient population with a shift
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and patient oriented care. This new organisation of care
includes, for example, involvement of a multidisciplinary
team, empowerment of the patient, patient education, a
central coordinating role for the GP, a possible coaching
role for the endocrinologist, and a quality of care monitor-
ing system [8].
The reflection on the need to change the present
health care system for T2DM and by extension for other
chronic diseases, was not only made in Belgium. In recent
years, new chronic care programmes were implemented
and evaluated in many other countries in and outside
Europe [9–20]. Most approaches tend to be disease-specific,
with T2DM most typically targeted. A common finding
in the evaluation is that the programmes are associated
with better diabetes care processes, but conclusions about
their impact on outcomes such as clinical parameters (e.g.
blood pressure, blood lipids, HbA1c), hospital admissions
and mortality vary from one study to another and are not
conclusive.
All these care programmes are to a large extent in-
spired by Wagner’s chronic care model (CCM).
For more than a decade, this CCM has been used to
transform daily care for patients with chronic illnesses
from an acute, reactive approach to a proactive, planned
approach [21–25].
In Belgium, the care trajectory (CT) for T2DM was in-
troduced by the NIHDI in 2009. This CT approach can
be considered as the first phase of implementation of
Wagner’s CCM in Belgium. First phase meaning that the
focus is on a specific disease and even on a limited sub-
set of T2DM patients and not on chronic diseases in
general. The Belgian T2DM-CT aims to improve delivery
of care and health outcomes by reinforcing proactively
planned, integrated, evidence-based, multidisciplinary care
for empowered patients [26]. It is focusing on patients in
an earlier phase of their disease, in contrast to diabetes
convention patients, who are often in a more advanced
stage of diabetes. CT-eligible patients include T2DM pa-
tients on one or two insulin injections or GLP-analogues
and those experiencing insufficient regulation with
maximum oral antidiabetic treatment excluding pregnant
women and T1DM patients [26].
The CT is defined by a four-year renewable contract
between patient, GP and specialist. This contract aims to
support the interaction between the three parties, each
of whom has to respect certain rules in order to receive
incentives. For example, after signing a CT contract, a
patient is reimbursed in full for encounters with his or
her GP and specialist [26]. He or she receives material
for self-monitoring, has improved access to a diabetes
educator/dietician and podiatrist, and receives partial re-
imbursement for these visits. On the other hand, the CT
contract also stipulates that the patient must have at leasttwo encounters a year with his or her GP and one encoun-
ter a year with the specialist.
Within the multidisciplinary care environment, the GP
acts as the coordinator of the medical management ac-
cording to an individualised care plan. The specialist’s
role is to keep the GP’s knowledge up-to-date and coach
him or her in relation to individual patients. In order to
facilitate multidisciplinary care, new local structures, known
as “local multidisciplinary networks” (LMN), were set up
with the financial support of the NIHDI. In these networks,
a new care manager function, the care trajectory promoter,
was introduced [26].
Before including the patient in a T2DM-CT programme,
the GP can eventually start a diabetes education and self-
management programme, in which only the GP provides
diabetes education and the patient receives free material
for self-monitoring of blood glucose [26]. There is no
multidisciplinary approach in this latter care programme.
Inclusion criteria for the patient are being treated with
either injectable incretinemimetics or one insuline in-
jection per day. If after one year of inclusion in this
programme the patient’s HbA1c level is not < 7.5 %,
the GP proposes the patient to join the T2DM-CT care
programme.
There is some overlap between the diabetes convention
3A and the T2DM-CT for patients on two insulin injec-
tions per day. Convention 3A patients can stay in the
convention or move to a T2DM-CT, but once in a
T2DM-CT, they are not allowed to switch to the con-
vention 3A [26].
The research project ACHIL (Ambulatory Care Health
Information Laboratory) assessed the adherence of CT
patients, in the early phases of CT programme imple-
mentation, to the CT rules; their uptake of incentives for
self-management; whether the CT programme was
targeting the appropriate group of patients; how care
processes for these patients evolved over time; and whether
inclusion in the CT led to better quality in the processes
and outcomes of care. Both crude effectiveness (proportion
of patients meeting a target value) and comparative effect-
iveness (comparison with a control group or over time)
were assessed. With regard to the latter, various groups
of T2DM patients were used: T2DM patients in a care
programme on diabetes education and self-management,
diabetes convention 3A patients on two insulin injections
a day, CT-eligible T2DM patients not included in a CT
and T2DM patients in no specifically dedicated care
programme.
This article describes an extract of the ACHIL project’s
T2DM-CT-related research objectives, the approach to
meeting these objectives, and some general results from
the early phases of T2DM-CT implementation. More
details on the methodology and some specific results are
reported elsewhere [27–31].
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Research domains, research questions and quality-related
parameters
Table 1 gives an overview of the research domains and
(quality-related) parameters considered in this article, to-
gether with the studied target frequency of measurement
and target outcome value. The research questions on
quality of care of diabetes were selected in accordance to
a 2006 report of the Belgian KCE on quality of T2DM
care [8] and the follow-up plan for the care trajectory
diabetes, developed by the National Council for Quality
Promotion and based upon the national recommendation
for good medical practice [32]. The KCE report classified
relevant guidelines and the resulting evidence based quality
indicators (at micro level) from international reference lit-
erature within major areas of diabetes care. Appropriate
target values to these quality indicators have been assigned.
The study method was based on a study evaluating the
diabetes convention carried out by the Intermutualistic
Agency [33] and on a study evaluating a diabetes care
quality improvement programme for general practitioners
that was carried out by the KU Leuven and the Universi-
teit Antwerpen [7, 34].Data sources
Four data sources were selected in order to answer the
research questions. Detailed information about the four
data sources is reported elsewhere [35].Table 1 Research domains and parameters under study for type 2 d
December 2011
Research domains Parameters studied
Recruitment of CT patients Number of enrolled patients
Mandatory parameters for all T2DM-CT
patients
HbA1c
LDL cholesterol
Blood pressure
BMI
Disease review Number of encounters with selecte
providers
Prescription of a glucometer
Primary revention Flu vaccination
Complications/secundary and tertiary
prevention
Diabetes education
Renal function
Statin use
OphthalmoscopyCentral pillar
This data source was the result of the compulsory re-
cording of four parameters (HbA1c, LDL cholesterol,
blood pressure and BMI), with at least one value per
parameter, by Belgian GPs for all T2DM-CT patients
(see Table 1). Data were entered by GPs using a secure
web application, either manually or with the help of auto-
matic data extraction from electronic patient records
(EPRs), encrypted and sent to the Scientific Institute of
Public Health [28, 29, 36]. The data collected cover the
period from 1 June 2008 to 31 December 2011, enabling
an observational retrospective cohort study.IMA pillar
This pillar drew on the Intermutualistic Agency (IMA)’s
administrative database of national compulsory health
insurance data which includes data from all seven Belgian
not-for-profit health insurance providers [37]. This data-
base contains information on all reimbursed medications,
medical and paramedical interventions and hospital ad-
missions as well as socio-demographic data on all Belgian
citizens who have health insurance. Data relevant to our
research questions were collected covering the period be-
tween 1 January 2006 and 31 December 2010, enabling
an observational retrospective cohort study. Data discussed
in this article concerned frequency of measurement for
HbA1c, LDL cholesterol, serum creatinine, number of
encounters with selected care providers, prescription ofiabetes care trajectory (T2DM-CT). 1 September 2009 – 31
Target frequency/target value
Freq: every 3 months
Target value: <7 %
Freq: every 3 months
Target value: <100 mg/dl
Freq: every 3 months
Target value: <130/80 mmHg
Freq: every 3 months
Target value: <25 kg/m2
d care 2 encounters/year with GP
1 encounter/year with internist
Number T2DM-CT patients with prescription of glucometer
Annual flu vaccination
At least 1 consultation with diabetes
educator/dietician
Freq: Serum creatinine 1×/year
All T2DM, except those without other cardiovascular risk factors
Freq: 1×/year
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educator and statin use.
Intego registration network
The Intego network, operational since 1997, is an EPR-
based network of 54 voluntarily participating GP practices
in Flanders, the northern region of the country, which all
use the same EPR software [38]. The network is coordi-
nated by the Academic Centre for General Practice at the
Katholieke Universiteit Leuven. The network covers ap-
proximately 1.95 % of the Flemish population. Information
was extracted on all encounters and included individual
demographic and administrative data, clinical and labora-
tory parameters, vaccinations and prescriptions.
The data used in this study covered the period between
1 January 2006 and 31 December 2011, enabling an ob-
servational retrospective cohort study. Data concerned
frequency of measurement and values for HbA1c, LDL
cholesterol, blood pressure, BMI, serum creatinine, flu
vaccination and statin use.
Sentinel network of general practices
The Belgian Sentinel Network of General Practices (SGP),
operational since 1979, is a paper-based nationwide net-
work which collects data from approximately 140 volun-
tarily participating practices on a limited set of parameters
related to specific health problems [39]. The network
covers about 1.5 % of the total Belgian population. Type
2 diabetes was among the themes recorded in 2010.
Cross-sectional data concerned the three most recent
values for HbA1c, blood pressure and weight, and the
most recent value for height and LDL cholesterol.
Data analysis
Logistic and continuous multilevel analyses were carried
out to study the effect of inclusion in the CT on achieving
a care process or a health outcome target, controlling for
potential confounders.Table 2 Characteristics of type 2 diabetes care trajectory patients by
Central pillar IMA pillar
Enrolment period 1 Sept 2009 – 31 Dec 2011 1 Sept 2009 – 30
Number of patients 18250 8528
Median study time 15 months 11 months
Ratio of men:women 1.08 1.03
Median age(group) 68y 65–69y
Geographic region
Flanders 83 % 89 %
Wallonia 13 % 9 %
Brussels Region 4 % 3 %
aMean instead of medianTriangulation of the four data sources was carried out
[40], as each source has its own strengths and weak-
nesses [35].
This article examines data from the early phases of CT
implementation and the years preceding the CT start.
The data used covered the period from 2006 to 2011.
Results
Number of T2DM-CT patients and their basic
characteristics
Table 2 describes the characteristics of the registered
T2DM-CT cases by data source. The age and sex distri-
butions and geographical spread of the four data sources
were comparable.
A considerable number of patients were already en-
rolled in a CT in this early phase of CT implementation,
as illustrated by the IMA and central pillar data.
Patients’ adherence with T2DM-CT obligations
According to the CT care programme rules, every CT
patient must have at least two encounters a year with his
or her GP and one encounter a year with the internist.
The IMA data indicate that 97 % (95 % CI: 96–97) of the
CT patients had at least two encounters with their GP
and 95 % (95 % CI: 94–95) had at least one encounter
with the specialist in the year 2010.
Patients’ uptake of measures for T2DM-CT self-care
The CT care programme facilitates self-monitoring of
glucose through prescription and reimbursement of a
glucometer. According to the IMA data, 50 % (95 % CI:
49–51) of the CT patients used this incentive in the
period September 2009 – December 2010. The CT care
programme also facilitates diabetes education by reimburs-
ing consultations. According to the IMA data, 58 % (95 %
CI: 56–59) of the CT patients had at least one consult-
ation with a diabetes educator or dietician in the period
September 2009 – December 2010.data source. 1 September 2009 – 31 December 2011
Intego SGP
June 2010 1 Sept 2009 – 31 Dec 2011 Cross-sectional data:
status on 31 Aug 2011
271 95
13 monthsa not applicable
1.08 0.79
69 ya 67y
100 % 80 %
0 % 13 %
0 % 7 %
Fig. 1 Proportion of diabetes type 2 care trajectory (CT) and non-CT
patients with > =3 HbA1c measurements around the CT start, IMA
pillar, 2006–2010. Proportion of diabetes type 2 (T2DM) care trajectory
(CT) patients with > = 3 HbA1c measures around CT start, in comparison
with T2DM patients on a diabetes convention 3A care programme
(two insulin injections a day, treated in specialised diabetic centres),
with T2DM patients in a care programme on diabetes education and
self-management and with T2DM patients in no dedicated care
programme
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after CT start
We observed a gradual improvement in the follow-up of
CT patients’ biological parameters, such as HbA1c and
LDL cholesterol, and clinical parameters, such as blood
pressure measurement, in the years before CT start (data
not shown). However, the target frequency with which
specific care processes should be carried out, had still not
been attained for a considerable proportion of patients.
This was the case, for instance, in the follow-up of oph-
thalmoscopy and flu vaccination, where according to the
IMA data of 2008 only 33 % (95 % CI: 32–34) of the pa-
tients had an ophthalmoscopy and 66 % (95 % CI: 65–67)
have been vaccinated against flu.
On top of the improvement observed in the care pro-
cesses during the years before CT start, we also saw a signifi-
cant increase, around the start of the CT, in the proportion
of CT patients receiving adequate care (Table 3).
After this significant increase, the process parameters
decreased slightly, but nevertheless remained at a higher
level than prior to CT start.
The significant increase in frequency of T2DM-CT pa-
tient follow-up, we observed around the start of the CT,
was far less notable among other T2DM patients (Fig. 1).
Outcome of care for T2DM-patients prior and after CT start
The T2DM-CT care programme recruited high-needs pa-
tients, who, according to the Intego network, prior to the
start of the CT, had higher HbA1c levels, more rapidly de-
clining renal function, and more diabetes-associated co-
morbidity compared to non-CT diabetic patients (Fig. 2).
CT patients were difficult to control in the years pre-
ceding the CT start. According to the SGP network, only
38 % (95 % CI: 28–48) of the CT patients had prior to
the CT start a HbA1c value <7 %, 11 % (95 % CI: 5–18)
had a blood pressure < 130/80 mmHg, and 8 % (95 % CI:
2–14) had a BMI <25 kg/m2. The proportion of CTTable 3 Process of care parameters around the type 2 diabetes
mellitus (T2DM) care trajectory (CT) start: degree of improvement
in follow-up per trimester around individual CT start dates. IMA
data, 2010, ACHIL project, Belgium
Process parameter Frequency of
measurement/year
Improvement 3 months
before CT start
Odds ratio (per trimester)
HbA1c ≥3 1.34*
LDL cholesterol ≥1 1.41*
Serum creatinine ≥1 1.42*
Ophtalmoscopy ≥1 1.15*
Statines ≥1 prescription 1.15*
Flu vaccination ≥1 vaccination 0.73* (per year)
A value above 1 indicates an improvement in time per trimester. The symbol*
after a value indicates that it is statistically significant, with p < 0.05diabetics with an LDL cholesterol <100 mg/dl, on the
other hand, was considerable (61 %, 95 % CI: 41–81).
However, about two thirds of these patients were taking
statins.
The central pillar data showed a significant decrease,
after CT start, in HbA1c among three cohorts of T2DM-
CT patients, with CT start in 2009, 2010 and 2011, respect-
ively (Fig. 3). This finding was confirmed by the Intego
dataset [30]. According to the central pillar data, T2DM-
CT patients also experienced a significant decrease in LDL
cholesterol, blood pressure and BMI after CT start (data
not shown). However, these findings were not confirmed
by the Intego dataset.
Discussion
This first phase of the ACHIL project aimed at studying
the impact of the T2DM-CT care programme on quality
of care, in terms of processes and outcomes, in the early
period of the CT care programme implementation.
The focus was on quality of care in its narrowest sense
(quality of technical care) in which practitioners’ perform-
ance is measured by looking at its effectiveness to realize
the achievable improvements in health status that have
been made possible by the current science and technology
of health care [41]. The assessment of quality of care in
this study was limited to two levels: process (what is ac-
tually done in giving and receiving care), and outcome
(effects of care on the health status of patients and pop-
ulations). Other dimensions of quality of care, such as
efficiency, patient and care providers satisfaction, were
not dealt with in the ACHIL project.
Fig. 2 Clinical status prior to care trajectory (CT) start in diabetes type 2 CT and non-CT patients, Intego network, 2006–2009. Proportion of patients
included and eligible patients not included in type 2 diabetes mellitus care trajectory, with HbA1c < 7 %, diabetes-associated co-morbidity and renal
function progression, prior to CT start
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T2DM patients had already been enrolled in the early
phase of the CT care programme implementation. More
than 50 % of the CT patients we studied were reimbursed
for a glucometer. This care programme was effective in
recruiting high-needs patients, who were difficult to
supervise and had already undergone a more intensive
follow-up prior to CT start. The vast majority of CT
patients had the required number of encounters with
their GP and the internist and more than 50 % had at
least one encounter a year with a diabetes educator or
dietician. The CT care programme also proved to be ef-
fective in improving the follow-up of the patients en-
rolled, compared to both their own follow-up in the past
and the follow-up of other diabetic patients. Despite the
emergence of a number of positive trends, however, no
conclusive results have yet been obtained in relation to
health outcome parameters.
By 31 December 2011, the central pillar data-set had
captured data on 18,250 T2DM-CT patients. Producing
a reliable estimation of the number of patients eligible
for a CT was impossible, however, due to the lack of
data on the occurrence of the inclusion and exclusioncriteria for a CT within the general population and the
difficulty of obtaining reliable estimates of T2DM preva-
lence in Belgium. Nevertheless, the number of CT patients
included in this study was considerable, and had increased
to 46,561 by September 2014, according to recent NIHDI
figures (NIHDI, personal communication).
According to the data provided by the Belgian Sentinel
Network of General Practices (SGP), 16 % (95 % CI: 13–19)
of all CT-eligible patients recorded by the network had
been included in a CT by the end of the surveillance period
in August 2011. The younger the CT-eligible patient, the
more likely he or she was to be included in a CT. Patients
living in Flanders (the northern region of the country) were
more likely to have been included than were patients living
in Wallonia (the southern region of the country). Motivated
patients with specific plans to change their diet were also
more likely to have been included in a CT. The most
frequently reported reasons for non-inclusion, as mentioned
by the GP, were the early timing of this study (inclusion
was to take place in the near future) and inclusion in the
diabetes convention 3A programme [31].
Despite the reimbursement facilities, consultations with
diabetes educators did not occur as frequently as expected
Fig. 3 HbA1c levels in diabetes type 2 care trajectory (CT) patients by year of CT start, central pillar data 2008–2011. HbA1c levels in diabetes type
2 care trajectory (CT) patients after CT start, for the cohort of CT patients who started the CT in 2009, 2010 and 2011
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could have contributed to this underuse, such as the
considerable administrative burden placed on GPs when
making referrals to educators, the low financial com-
pensation provided to educators, the insufficient amount
of time allotted per education session, the lack of an
accreditation system for diabetes educators, or patient
factors other than financial incentives (e.g., perceived
seriousness of the illness, external locus of control, low
perceived self-efficacy, lack of social support,…).
The increased follow-up of various process parameters
observed among T2DM-CT patients can be considered as
an improvement in quality of care, as defined in evidence-
based guidelines. For several of these process parameters,
however, there is still considerable room for improvement.
This is the case, for instance, for the yearly ophthalmos-
copy exam, for which under 50 % of the CT patients
we studied conformed to the recommended frequency
of follow-up.
Despite the emergence of a number of positive trends
in health outcomes, no conclusive results have been ob-
tained to date: a decrease in HbA1c, LDL cholesterol orblood pressure among T2DM-CT patients cannot neces-
sarily be attributed to the CT programme. Additionally,
an improvement in outcomes found in one data source
was not always confirmed by another source. Any im-
provements in outcome were also rather small and it
seems premature to consider them obvious improvements
in a patient’s health status (with slower disease progression
as a result). Further research is needed to assess the trends
in health outcomes due to the T2DM-CT.
The findings of this study corroborate with the evalu-
ation results of other care programmes for chronic dis-
ease management in various countries in and outside
Europe [9–20].
A criticism of the Belgian diabetes CT care programme
is its focus on patients who already have advanced dia-
betes. While our results show that targeting this group
of diabetics is justified, it is also known that the greatest
benefit in terms of health and costs could be achieved
by treating early-diagnosed patients well [42, 43]. The
need to extend this diabetes care programme has been
recognised by the Belgian public health authorities and is
presently under discussion. A second issue to be tackled is
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convention 3A care programme, which to some extend
target the same patients.
Another criticism of the Belgian CT care programme
is the lack of a holistic approach. To date, two different
CT programmes exist, one for T2DM and another for
chronic renal failure. However, co-morbidity has not been
taken into account in this approach, although the vast
majority of elderly people have at least two chronic dis-
orders. This criticism has also been recognised by the
health authorities and therefore, the NIHDI recently
established a working group on T2DM and multimorbidity.
This study has a number of limitations that should be
acknowledged. The Belgian CT care programme is an ex-
ample of a complex intervention, consisting of various
elements: a contract, patient education measures, re-
imbursement of various consultations and self-control
material, multidisciplinary local structures, and so on.
The effectiveness studied here, concerns the CT care
programme as a whole and not the individual elements.
The ACHIL project only focused on the effectiveness
of the T2DM-CT programme in terms of quality of care
processes and outcome. The CT being a complex inter-
vention, it is likely that the participation of the patients
and the effectiveness of the program not only depends
on the program itself, but also, among other factors, on
the patients’ level of (health) literacy. The role of health
literacy as a moderator of diabetes treatment effective-
ness has been documented in the literature [44]. Besides,
the same complexity could be a reason for the imple-
mentation fidelity of the program to be limited. Imple-
mentation fidelity in diabetes self-management programs
is also mentioned as a potential mediating factor of
effectiveness [45].
Another limitation of this study is that it concerns an
observational study, which has a number of shortcomings
compared to a randomised controlled study. Patients who
were eligible for a CT, but not enrolled, were difficult to
define in the data sources and, in addition, could not serve
entirely as a control group for the CT patients. Besides
this, the observation period was very short: no data were
included after 2011, although the CT care programme
started only in the summer of 2009. In the central data pil-
lar, automatic extraction from EPRs appeared to be more
promising than manual data entry. In 2012, however, only
9 % of all CT patients’ data were extracted from the EPR
and many fields remained incomplete.
An important strength of this study is the fact that it
involved the first large-scale (partly EPR-based) data col-
lection, and included all GPs and CT patients. Another
strength of the study is the use of triangulation between
the four data sources. The conclusions of this study are
based on congruent results obtained from the various data
pillars, thus enforcing the validity of the conclusions andthe validity of each data source individually. The frame-
work of four different data sources developed here can be
considered as an important basis for further evaluation of
the effectiveness of the Belgian CT care programme.
Conclusions
In 2009, the NIHDI introduced care trajectories (CTs), a
chronic disease management programme involving com-
plex interventions. The evaluation of this programme’s
implementation is essential for the public health author-
ities. An important aspect of this evaluation consists of
studying the effectiveness of the CT care programme with
regard to the quality of care delivered and the outcome of
care for patients. This study deals with this evaluation in
the early phases of its implementation.
The ACHIL study found that, in the period 2009–2011,
the CT care programme was effective in recruiting high-
needs patients and in improving the processes of care
for those patients. To date, however, no conclusive results
have been obtained regarding the impact of the care
programme on patient health outcomes.
As a result of this study, we recommend confirming the
improvements found in care processes; further investi-
gating patient health status outcomes and strengthening
quality improvement by means of quality circles (plan-do-
check-act). In order to achieve these recommendations, a
longer observation period is needed, in combination with
improved automatic data extraction from EPRs, monitor-
ing of this improvement, linkage of data from EPRs with
reimbursement data, extension of compulsory parameters
in the central pillar and continuation of the triangulation
between multiple data sources.
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